Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What definitive dose would you use to treat a recurrent basal cell carcinoma in the oral cavity?
Would you hypofractionate at all? Or use standard H&N doses of 70 Gy/35 fractions?
Answer from: Radiation Oncologist at Academic Institution
I don’t recall seeing a BCC in the oral cavity. Lips? 66-70 Gy at 2 Gy per fraction.
Comments
Radiation Oncologist at UH Seidman Cancer Center, Case Western Reserve University
Thanks @William M. Mendenhall! In this partic...
Radiation Oncologist at University of Florida
Got it. 70 Gy/35 fractions
9434
9437
Sign In
or
Register
to read more
18257
Related Questions
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
For an upper lip (near midline) Merkel Cell Carcinoma s/p wide local excision with negative SLNB and no adjuvant RT with recurrence to one side of the neck a year later, should the contralateral neck be included in the radiation field?
How would you manage a presumed radiation induced sarcoma of the head and neck?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
Thanks @William M. Mendenhall! In this partic...
Got it. 70 Gy/35 fractions